176
Views
14
CrossRef citations to date
0
Altmetric
Review

Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations

, MSc, , MD, PhD, , D Math Sc, PhD, , MSc, , MB ChB, MRCPI MD, , MD, , MSc, , MD, PhD, , MD, PhD, , Pharm D, PhD, , MSc, , PhD, , MD, PhD & , MD, PhD show all
Pages 1787-1799 | Published online: 14 Aug 2007
 

Abstract

The area of pharmacogenetics (PGt) is evolving rapidly. However, ongoing efforts in this field are not aligned with the requirements for the inclusion of clinically relevant findings into the label, especially with reference to paediatric indications. Clinical research in children poses unique issues from a practical and technical perspective, but many challenges can be overcome by applying advanced study design and data analysis methods. When investigating the role of PGt factors on treatment effect, all features that influence drug response must be taken into account. Yet, PGt often has a privileged status in research protocols, with PGt factors evaluated independently from other determinants of response, instead of being regarded as other demographic or clinical covariates (e.g., age, renal function). At present, guidelines to incorporate PGt findings into label statements are lacking in part because this is a new and incompletely understood area. This situation is no longer acceptable. To achieve the potential that PGt can offer to drug development and ultimately to drug prescription, academia, industry and regulatory agencies need to pool resources on the revision of study design and data analysis requisites, bringing in model-based methodologies to enable accurate interpretation of results and provide appropriate labelling recommendations.

Acknowledgements

This publication is the result of concerted efforts by Taskforce in Europe for Drug Development in the Young (TEDDY) Network of Excellence, a project under the auspices of the European Union's Sixth Framework Programme.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.